138 related articles for article (PubMed ID: 7134032)
1. The stability and metabolism of intravenously administered neurotensin in the rat.
Aronin N; Carraway RE; Ferris CF; Hammer RA; Leeman SE
Peptides; 1982; 3(4):637-42. PubMed ID: 7134032
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral fat on plasma levels of neurotensin and neurotensin fragments in humans. Characterization by high-pressure liquid chromatography.
Draviam EJ; Upp JR; Greeley GH; Townsend CM; Thompson JC
Dig Dis Sci; 1990 Feb; 35(2):200-4. PubMed ID: 2302977
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma.
Lee YC; Allen JM; Uttenthal LO; Walker MC; Shemilt J; Gill SS; Bloom SR
J Clin Endocrinol Metab; 1984 Jul; 59(1):45-50. PubMed ID: 6725524
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of neurotensin and pancreatic polypeptide in man: role of the kidney and plasma factors.
Shulkes A; Bijaphala S; Dawborn JK; Fletcher DR; Hardy KJ
J Clin Endocrinol Metab; 1984 May; 58(5):873-9. PubMed ID: 6707191
[TBL] [Abstract][Full Text] [Related]
5. Tubular handling of neurotensin in the rat kidney as studied by micropuncture and HPLC.
Bjerke T; Christensen EI; Boye N
Am J Physiol; 1989 Jan; 256(1 Pt 2):F100-6. PubMed ID: 2912155
[TBL] [Abstract][Full Text] [Related]
6. Release and degradation of neurotensin during perfusion of rat small intestine with lipid.
Ferris CF; Carraway RE; Hammer RA; Leeman SE
Regul Pept; 1985 Oct; 12(2):101-11. PubMed ID: 3840906
[TBL] [Abstract][Full Text] [Related]
7. Organ and plasma metabolism of neurotensin in sheep.
Shulkes A; Fletcher DR; Hardy KJ
Am J Physiol; 1983 Nov; 245(5 Pt 1):E457-62. PubMed ID: 6638173
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin in plasma: immunochemical and chromatographic character of acid/acetone-soluble material.
Carraway R; Hammer RA; Leeman SE
Endocrinology; 1980 Aug; 107(2):400-6. PubMed ID: 7389661
[TBL] [Abstract][Full Text] [Related]
9. The simultaneous determination of neurotensin and its major fragments by on-line trace enrichment HPLC with electrochemical detection.
Kilts CD; Knight DL; Nemeroff CB
Life Sci; 1996; 59(11):911-20. PubMed ID: 8795702
[TBL] [Abstract][Full Text] [Related]
10. Relation between lower esophageal sphincter (LES) pressure and the plasma concentration of neurotensin during intravenous infusion of neurotensin(1-13) and (Gln4)neurotensin(1-13) in man.
Theodorsson-Norheim E; Thor K; Rosell S
Acta Physiol Scand Suppl; 1983; 515():29-35. PubMed ID: 6578671
[TBL] [Abstract][Full Text] [Related]
11. Evidence for biological activity of two N-terminal fragments of neurotensin, neurotensin1-8 and neurotensin1-10.
Hernandez DE; Richardson CM; Nemeroff CB; Orlando RC; St-Pierre S; Rioux F; Prange AJ
Brain Res; 1984 May; 301(1):153-6. PubMed ID: 6329440
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
[TBL] [Abstract][Full Text] [Related]
13. The N-terminal neurotensin fragment, NT1-11, inhibits cortisol secretion by human adrenocortical cells.
Sicard F; Contesse V; Lefebvre H; Ait-Ali D; Gras M; Cartier D; Decker A; Chartrel N; Anouar Y; Vaudry H; Delarue C
J Clin Endocrinol Metab; 2006 Aug; 91(8):3131-7. PubMed ID: 16705076
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of neurotensin by isolated perfused rat kidney.
Gillatt DJ; Shulkes A; Read DM; Hardy KJ
Am J Physiol; 1990 Jun; 258(6 Pt 1):E930-6. PubMed ID: 2360626
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin metabolism in the rat: contribution of the kidney.
Shulkes A; Englin I; Read D; Hardy KJ
Peptides; 1987; 8(6):961-5. PubMed ID: 3126491
[TBL] [Abstract][Full Text] [Related]
16. Hepatic metabolism of neurotensin.
Brook CW; Shulkes A; Sewell RB; Smallwood RA
Endocrinology; 1987 Apr; 120(4):1397-402. PubMed ID: 3549259
[TBL] [Abstract][Full Text] [Related]
17. Intact neurotensin (NT) in human plasma: response to oral feeding.
Shaw C; Buchanan KD
Regul Pept; 1983 Oct; 7(2):145-53. PubMed ID: 6197723
[TBL] [Abstract][Full Text] [Related]
18. Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal.
Lee YC; Allen JM; Uttenthal LO; Roberts PM; Gill SS; Bloom SR
Dig Dis Sci; 1985 Feb; 30(2):129-33. PubMed ID: 3838153
[TBL] [Abstract][Full Text] [Related]
19. Elevation of plasma neurotensinlike immunoreactivity after a meal. Characterization of the elevated components.
Hammer RA; Carraway RE; Leeman SE
J Clin Invest; 1982 Jul; 70(1):74-81. PubMed ID: 7085889
[TBL] [Abstract][Full Text] [Related]
20. Differential processing of the neurotensin/neuromedin N precursor in the mouse.
Shaw C; McKay D; Johnston CF; Halton DW; Fairweather I; Kitabgi P; Buchanan KD
Peptides; 1990; 11(2):227-35. PubMed ID: 2356154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
